FDA Taking Steps To Simplify Combo Product Consultations
This article was originally published in The Tan Sheet
Executive Summary
The agency releases an internal assessment of how it handles inter-center consultations for combination products. As expected, there are some serious challenges to collaboration between the centers, but FDA says it is taking tangible steps to make it better.
You may also be interested in...
Companies Want New US FDA Council To Help Resolve Inter-Agency Combo Product Disputes
A range of topics were raised in feedback provided by industry groups to FDA about what the priorities should be for the agency's new Combination Products Policy Council, but addressing inter-center disagreements was a repeat concern. Also raised: misaligned communication policies; pediatric combo-product reviews; and implementation of the 21st Century Cures Act.
Be Careful What You Ask For With Combo Product Designation Requests
Companies should carefully consider their moves for ensuring proper evaluation of combination product applications, including looking at whether a formal request for designation really is needed, say industry and legal experts.
Be Careful What You Ask For With Combo Product Designation Requests
Companies should carefully consider their moves for ensuring proper evaluation of combination product applications, including looking at whether a formal request for designation really is needed, say industry and legal experts.